Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
基本信息
- 批准号:8912638
- 负责人:
- 金额:$ 33.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAdvocateAnimalsBasic ScienceBehaviorBehavioralCharacteristicsChronicCocaineCognitive TherapyConsumptionControl LocusCorpus striatum structureCuesDataData SetDiseaseDopamineDrug AddictionDrug ControlsDrug RegulationsDrug abuseDrug usageDrug userEmployee StrikesExhibitsExtinction (Psychology)Harm ReductionHourHumanIndividual DifferencesIntakeMeasuresModelingMonitorNucleus AccumbensPatternPeripheralPharmaceutical PreparationsProbabilityRattusRecording of previous eventsRecreational DrugsRegimenRelapseScanningSelf AdministrationSignal TransductionStimulusSubstance abuse problemTestingTimeWithdrawalWorkaddictionbehavioral responsecocaine usecravingdecarboxylase inhibitordrug cravingdrug withdrawalindexingneurochemistrypublic health relevancerecreational drug useresponsespatiotemporaltheoriestraittransmission process
项目摘要
DESCRIPTION (provided by applicant): Altered dopamine transmission is implicated in most contemporary theories of drug abuse, but the manner and even the direction of these changes are quite controversial. The most salient behavioral characteristics of the switch from recreational drug use to drug abuse are an increased focus on drug seeking and increased drug consumption. We recently demonstrated that increased drug consumption following chronic use is driven by a decrement in a specific dopamine signal: phasic dopamine release evoked by the response- contingent presentation of drug cues. However, our preliminary data indicate that phasic dopamine release to non-contingent presentation of drug cues (i.e., a potent stimulus for drug seeking and relapse to drug use during abstinence) change in the opposite direction and actually increase with chronic drug use. Collectively, this notion of diametric changes in phasic dopamine release to contingent and non-contingent drug cues, respectively, can resolve apparently contradictory theories of drug addiction. In the proposed work we will test this hypothesis by measuring dopamine release with fast-scan cyclic voltammetry and observing behavior to drug-related cues using different regimens of cocaine self-administration and following periods of drug withdrawal. We will also test whether or not the effect of L-DOPA on restoring dopamine release to contingent presentation of drug cues to reduce drug consumption is mitigated by increasing dopamine release to non-contingent cues and potentially increasing the likelihood of relapse. If not, and L-DOPA selectively increases depleted dopamine release (to contingent cues) without significantly elevating non- depleted dopamine (to contingent cues), we would advocate L-DOPA as a harm-reduction pharmacotherapeutic for reducing drug consumption to provide a window for behavioral and cognitive interventions.
描述(由申请人提供):多巴胺传递的改变与大多数当代药物滥用理论有关,但这些变化的方式甚至方向都存在争议。从娱乐性药物使用转向药物滥用的最突出的行为特征是更加注重寻求药物和增加药物消费。我们最近证明,长期使用后药物消耗的增加是由特定多巴胺信号的减少驱动的:由药物线索的响应-视情况呈现诱发的阶段性多巴胺释放。然而,我们的初步数据表明,阶段性多巴胺释放对药物线索的非偶然呈现(即,在戒毒期间对寻求毒品和吸毒复吸的一种强有力的刺激)向相反的方向变化,实际上随着长期吸毒而增加。总的来说,这个概念的直径变化阶段多巴胺释放的偶然性和非偶然的药物线索,分别可以解决明显矛盾的理论药物成瘾。在拟议的工作中,我们将测试这一假设,通过测量多巴胺的释放与快速扫描循环伏安法和观察行为的药物相关的线索使用不同的方案可卡因自我管理和以下时期的药物戒断。我们还将测试左旋多巴对恢复多巴胺释放到药物线索的偶然呈现以减少药物消耗的影响是否通过增加多巴胺释放到非偶然线索并潜在地增加复发的可能性来减轻。如果没有,并且L-DOPA选择性地增加耗尽的多巴胺释放(对偶然线索)而不显著升高未耗尽的多巴胺(对偶然线索),我们将提倡L-DOPA作为减少药物消耗的减少伤害的药剂,以提供行为和认知干预的窗口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul E. M. Phillips其他文献
Making risk-takers settle
让冒险者安顿下来
- DOI:
10.1038/nature17314 - 发表时间:
2016-03-23 - 期刊:
- 影响因子:48.500
- 作者:
Nick G. Hollon;Paul E. M. Phillips - 通讯作者:
Paul E. M. Phillips
Calculating utility: preclinical evidence for cost–benefit analysis by mesolimbic dopamine
- DOI:
10.1007/s00213-006-0626-6 - 发表时间:
2006-11-22 - 期刊:
- 影响因子:3.300
- 作者:
Paul E. M. Phillips;Mark E. Walton;Thomas C. Jhou - 通讯作者:
Thomas C. Jhou
Paul E. M. Phillips的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul E. M. Phillips', 18)}}的其他基金
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10215470 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10399567 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10612394 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10035032 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
- 批准号:
9230365 - 财政年份:2015
- 资助金额:
$ 33.99万 - 项目类别:
8/8 NADIA UO1 Adolescent Alcohol and Decision Making
8/8 NADIA UO1 青少年酒精与决策
- 批准号:
9762555 - 财政年份:2015
- 资助金额:
$ 33.99万 - 项目类别:
2013 Catecholamines Gordon Research Conference and Gordon Research Seminar
2013年儿茶酚胺戈登研究会议暨戈登研究研讨会
- 批准号:
8593885 - 财政年份:2013
- 资助金额:
$ 33.99万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8413188 - 财政年份:2012
- 资助金额:
$ 33.99万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8733509 - 财政年份:2012
- 资助金额:
$ 33.99万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8549099 - 财政年份:2012
- 资助金额:
$ 33.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.99万 - 项目类别:
Research Grant














{{item.name}}会员




